Using Box Spread to Determine Implied Dividend and Risk-free Rate Simultaneously

Follow us on LinkedIn

Dividends are a fundamental component of many investment strategies and a crucial aspect of equity ownership. They represent a portion of a company’s profits that is distributed to its shareholders, typically on a regular basis, such as quarterly or annually. Dividends are an input in the pricing model for equity options. When valuing options, the timing and magnitude of expected dividend payments are essential considerations. These payments can affect the option’s value by altering the future cash flows associated with owning the underlying stock.

Dividends can be estimated using historical dividend payouts. However, for stocks with traded options, dividends can be calculated or implied from traded option prices. We can utilize the put-call parity to derive the implied dividend. However, using this approach requires prior knowledge of the risk-free interest rate.

Reference [1] introduced a method for simultaneously determining the implied dividend and risk-free interest rate based on the no-arbitrage principle. This approach relies on utilizing the box spread to establish an equation for calculating both the implied dividend and the risk-free rate. The authors pointed out,

In this article, a simple no-arbitrage methodology allowing for the simultaneous estimation of option-implied interest rates and dividend yields via a robust estimation method has been proposed. The estimators for the slope and intercept are derived from first principles via the no-arbitrage relationship, clearly demonstrating the link between the sloped asset position with the intercept and the box spread with the slope. Using market options data, robust forward-looking model-free estimates of the interest rate and dividend yield are obtained, with the robustness of the repeated median estimator being more pronounced even for heteroscedastic data.

This approach is useful for determining the implied dividend yield, offering valuable assistance to dividend investors in the effective management of their dividend-paying stock portfolios. We observe, however, that the derivation is applicable to European options only. It would be interesting to extend the formula to American options.

Let us know what you think in the comments below or in the discussion forum.

References

[1] Muoria Kamau & Ivivi J. Mwaniki, On a robust estimation of option-implied interest rates and dividend yields, Cogent Economics & Finance, 11:2, 2260658, DOI: 10.1080/23322039.2023.2260658

Further questions

What's your question? Ask it in the discussion forum

Have an answer to the questions below? Post it here or in the forum

LATEST NEWSArm CEO Fears Humans Could Lose Control of AI
Arm CEO Fears Humans Could Lose Control of AI

“The thing I worry about most is humans losing capability” over the machines, said  Rene Haas, Chief Executive Officer of Arm Holdings Plc, when asked what keeps him up at night when he thinks about artificial intelligence. “You need some override, some backdoor, some way that the system…

Stay up-to-date with the latest news - click here
LATEST NEWSKim Jong Un might be one of the few world dictators who has been seen crying
Kim Jong Un might be one of the few world dictators who has been seen crying

North Korean leader Kim Jong Un was seen crying on national television during a speech in which he addressed North Korea's declining birthrate.

Stay up-to-date with the latest news - click here
LATEST NEWSChina, Japan trade blame over confrontation near disputed islands
China, Japan trade blame over confrontation near disputed islands
Stay up-to-date with the latest news - click here
LATEST NEWSMusk poll shows X users want U.S. conspiracy theorist Jones' account back
Musk poll shows X users want U.S. conspiracy theorist Jones' account back
Stay up-to-date with the latest news - click here
LATEST NEWSInnate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023

Results confirm promising clinical activity, durable responses and favorable safety of lacutamab in heavily pretreated post-mogamulizumab Sézary Syndrome patients. Virtual KOL event will be held on Tuesday, December 12, 2023 at 7:00AM PST (4:00PM CET) MARSEILLE, France — Innate Pharma SA (Euronext Paris: IPH; Nasdaq:…

Stay up-to-date with the latest news - click here

Leave a Reply